PMID- 36158632
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220928
IS  - 1948-5190 (Print)
IS  - 1948-5190 (Electronic)
VI  - 14
IP  - 8
DP  - 2022 Aug 16
TI  - Percutaneous transluminal angioplasty balloons for endoscopic ultrasound-guided 
      pancreatic duct interventions.
PG  - 487-494
LID - 10.4253/wjge.v14.i8.487 [doi]
AB  - BACKGROUND: Endoscopic ultrasound (EUS)-guided main pancreatic duct (PD) access 
      may be used when conventional endoscopic retrograde cholangiopancreatography 
      (ERCP) techniques fail. The use of a percutaneous transluminal angioplasty 
      balloon (PTAB), originally developed for vascular interventions, can be used to 
      facilitate transmural (e.g., transgastric) PD access and to dilate high-grade 
      pancreatic strictures. AIM: To describe the technique, efficacy, and safety of 
      PTABs for EUS-guided PD interventions. METHODS: Patients who underwent EUS with 
      use of a PTAB from March 2011 to August 2021 were retrospectively identified from 
      a tertiary care medical center supply database. PTABs included 3-4 French 
      angioplasty catheters with 3-4 mm balloons designed to use over a 0.018-inch 
      guidewire. The primary outcome was technical success. Secondary outcomes included 
      incidence of adverse events (AEs) and need for early reintervention. RESULTS: A 
      total of 23 patients were identified (48% female, mean age 55.8 years). Chronic 
      pancreatitis was the underlying etiology in 13 (56.5%) patients, surgically 
      altered anatomy (SAA) with stricture in 7 (30.4%), and SAA with post-operative 
      leak in 3 (13.0%). Technical success was achieved in 20 (87%) cases. Overall AE 
      rate was 26% (n = 6). All AEs were mild and included 1 pancreatic duct leak, 2 
      cases of post-procedure pancreatitis, and 3 admissions for post-procedural pain. 
      No patients required early re-intervention. CONCLUSION: EUS-guided use of PTABs 
      for PD access and/or stricture management is feasible with an acceptable safety 
      profile and can be considered in patients when conventional ERCP cannulation 
      fails.
CI  - (c)The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights 
      reserved.
FAU - AbiMansour, Jad P
AU  - AbiMansour JP
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Abu Dayyeh, Barham K
AU  - Abu Dayyeh BK
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Levy, Michael J
AU  - Levy MJ
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Storm, Andrew C
AU  - Storm AC
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Martin, John A
AU  - Martin JA
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Petersen, Bret T
AU  - Petersen BT
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Law, Ryan J
AU  - Law RJ
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Topazian, Mark D
AU  - Topazian MD
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States.
FAU - Chandrasekhara, Vinay
AU  - Chandrasekhara V
AD  - Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, 
      United States. chandrasekhara.vinay@mayo.edu.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - World J Gastrointest Endosc
JT  - World journal of gastrointestinal endoscopy
JID - 101532474
PMC - PMC9453307
OTO - NOTNLM
OT  - Anastomotic stricture
OT  - Chronic pancreatitis
OT  - Dilating balloon
OT  - Pancreatic duct intervention
COIS- Conflict-of-interest statement: Andrew C Storm is a consultant for Apollo 
      Endosurgery; and received research support from Apollo Endosurgery and Boston 
      Scientific. Ryan J Law is a consultant for ConMed and Medtronic and receives 
      royalties from UpToDate. Bret T Petersen is a consultant for Olympus America and 
      investigator for Boston Scientific and Ambu. Barham K Abu Dayyeh reports 
      consultant roles with Endogenex, Endo-TAGSS, Metamodix, and BFKW; consultant and 
      grant or research support from USGI, Cairn Diagnostics, Aspire Bariatrics, Boston 
      Scientific; speaker roles with Olympus, Johnson and Johnson; speaker and grant or 
      research support from Medtronic, Endogastric solutions; and research support from 
      Apollo Endosurgery and Spatz Medical. Vinay Chandrasekhara is a consultant for 
      Covidien LP, is on the advisory board for Interpace Diagnostics, and is a 
      shareholder in Nevakar, Inc. The remaining authors have no conflicts or funding 
      to disclose.
EDAT- 2022/09/27 06:00
MHDA- 2022/09/27 06:01
PMCR- 2022/08/16
CRDT- 2022/09/26 17:23
PHST- 2022/02/14 00:00 [received]
PHST- 2022/04/19 00:00 [revised]
PHST- 2022/07/22 00:00 [accepted]
PHST- 2022/09/26 17:23 [entrez]
PHST- 2022/09/27 06:00 [pubmed]
PHST- 2022/09/27 06:01 [medline]
PHST- 2022/08/16 00:00 [pmc-release]
AID - 10.4253/wjge.v14.i8.487 [doi]
PST - ppublish
SO  - World J Gastrointest Endosc. 2022 Aug 16;14(8):487-494. doi: 
      10.4253/wjge.v14.i8.487.